Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancerKevin Lin, Kris C. Wood, Raphaël Itzykson et al.|Nature Genetics|2020Cited by 91
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Alexandre Puissant, Frank Ling et al.|Cancer Discovery|2020Cited by 26
A multiparametric niche-like drug screening platform in acute myeloid leukemiaReinaldo Dal Bello, Raphaël Itzykson, Justine Pasanisi et al.|Blood Cancer Journal|2022Cited by 13
Data from The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Alexandre Puissant, Frank W. Ling et al.|Unknown|2023Cited by 0
Figure S10 from The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Alexandre Puissant, Frank W. Ling et al.|Unknown|2023Cited by 0